NEI
GH icon

Northwest & Ethical Investments’s Guardant Health GH Stock Holding History

Northwest & Ethical Investments’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Sell
2,786
-8,069
-74% -$878K 0.01% 347
2026
Q1 		$973K Buy
10,855
+3,655
+51% +$367K 0.02% 315
2025
Q4 		$724K Buy
+7,200
New +$644K 0.02% 349

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Northwest & Ethical Investments's GH Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Guardant Health (GH) stake by 74% in Q2 2026, selling an estimated $878K and leaving 2,786 shares worth $428K. The position accounts for 0.01% of the portfolio, ranked #347.

Northwest & Ethical Investments first reported a position in GH in Q4 2025 and has held it in 3 quarters since. The position peaked at $973K in Q1 2026. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Northwest & Ethical Investments held 2,786 shares of Guardant Health worth $428K as of Q2 2026.
  • Northwest & Ethical Investments sold 8,069 Guardant Health shares in Q2 2026, an estimated $878K.
  • Guardant Health made up 0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #347 holding.
  • Northwest & Ethical Investments first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • Northwest & Ethical Investments's Guardant Health position peaked at $973K in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.